Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer

Autor: Hung, Shuen-Iu a, b, ⁎, 1, Chu, Mu-Tzu a, Hou, Ming-Mo c, d, 2, Lee, Yun-Shien e, f, 3, Yang, Chan-Keng c, d, 4, Chu, Sung-Yu g, 5, Liu, Feng-Yuan d, h, i, j, 6, Hsu, Hung-Chih c, d, 7, Pao, Shih-Cheng a, b, Teng, Yu-Chuan e, Chen, Chun-Bing d, k, 8, Chao, Angel d, i, l, 9, Chung, Wen-Hung a, d, k, m, 10, Chang, John Wen-Cheng c, d, 11, Lai, Chyong-Huey d, i, l, ⁎⁎, 12
Zdroj: In Biomedicine & Pharmacotherapy 31 December 2023 169
Databáze: ScienceDirect
Externí odkaz: